Endo International Plc offered to acquire Auxilium Pharmaceuticals Inc for about $2.2 billion in cash and stock. The offer of $28.10 per share represents a premium of 30.6 percent to Auxilium's Tuesday closing price of $21.52 on the Nasdaq.
Auxilium Pharmaceuticals, Inc. is a specialty biopharmaceutical company focuses on developing and marketing products to predominantly specialist audiences. Shares of AUXL fell by 1.56% or $-0.34/share to $21.52. In the past year, the shares have traded as low as $16.36 and as high as $32.89. On average, 1233350 shares of AUXL exchange hands on a given day and today's volume is recorded at 906042.
Source
